ASX:BIOHousehold & Personal ProductsPersonal Care Products
Biome Australia Ltd
$0.265
+$0.040 (+17.78%)
Day Range
$0.240 – $0.275
52 Week Range
$0.200 – $0.630
Volume
801.85K
Avg Volume (10D)
209.28K
Market Cap
$60.42M
P/E Ratio
229.59
Price Chart
Market Statistics
Open$0.240
Previous Close$0.225
Day High$0.275
Day Low$0.240
52 Week High$0.630
52 Week Low$0.200
Valuation
Market Cap60.42M
Shares Outstanding228.00M
P/E Ratio (Annual)229.59
P/E Ratio (TTM)53.57
Price to Book8.27
Trading Activity
Volume801.85K
Value Traded208.55K
Bid$0.260 × 71,730
Ask$0.265 × 12,260
Performance
1 Day-3.23%
5 Day-15.09%
13 Week-44.44%
52 Week-51.09%
YTD-46.43%
Technical Indicators
RSI (14)48.87
50-Day SMA$0.298
200-Day SMA$0.408
Latest News
Biotechnology
Biome Australia to Commence Domestic Production of Activated Probiotics Range
Biome Australia moves to onshore production of Activated Probiotics, targeting margin rise from 61% toward 65%+ as inventory and lead times shrink.
Biotechnology
Biome Australia Extends Exclusive Probiotical Supply Agreement Through 2028
Biome Australia extends exclusive Probiotical supply to 2028, securing supply amid expansion; H1 FY2026 revenue $12.4m, EBITDA-positive.
Biotechnology
Biome Australia Surges with 41% YoY Revenue Growth in Q2 FY26
Biome Australia (ASX: BIO) has reported a robust Q2 FY26, with revenue surging 40.9% year-on-year to $6.48 million, significantly exceeding expectations and reinforcing its trajectory towards its 'Vis
Biotechnology
Biome Australia Launches First Human Clinical Trial on Proprietary BMB18 Strain
Biome Australia (ASX: BIO) has submitted ethics approval and registered its first human clinical trial on proprietary probiotic strain Lactobacillus plantarum BMB18 with the Australia New Zealand Clinical Trials Registry.